Icomb 10 Mg/5 Mg (Ramipril, Amlodipine Besilate)

Ramipril is an angiotensin‑converting enzyme (ACE) inhibitor. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, leading to reduced vasoconstriction, decreased aldosterone secretion, and ultimately lower systemic blood pressure.

The dosage of Icomb 10 Mg/5 Mg is determined by the prescribing clinician based on the individual’s blood pressure, renal function, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Icomb during pregnancy or lactation has not been established. Ramipril is generally contraindicated in pregnancy because of potential fetal toxicity, and amlodipine should be used only if the benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Icomb 10 Mg/5 Mg, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Icomb combines an ACE inhibitor (ramipril) with a calcium‑channel blocker (amlodipine), offering complementary blood‑pressure reduction. Compared with monotherapy, the combination can achieve better control with a single tablet, potentially improving adherence. It differs from other combos such as lisinopril‑hydrochlorothiazide by targeting both the renin‑angiotensin system and vascular calcium channels.

Icomb tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the label.

Icomb is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious risks include angioedema (rapid swelling of the face, lips, tongue, or throat), severe hypotension, and hepatic dysfunction. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden dizziness, or signs of liver injury such as jaundice.

Icomb should be avoided in individuals with known hypersensitivity to ramipril, amlodipine, or any tablet excipients. It is also contraindicated in patients with a history of angioedema related to ACE‑inhibitor therapy, severe aortic stenosis, or those taking aliskiren concomitantly if they have diabetes.